Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model

Background Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after cytoreductive surgery (CRS). During HIPEC, fluid (41–43 °C) is administered and drained through a limited number of catheters, risking thermal and drug heterogeneities within the...

Full description

Bibliographic Details
Main Authors: Daan R. Löke, Roxan F. C. P. A. Helderman, Hans M. Rodermond, Pieter J. Tanis, Geert J. Streekstra, Nicolaas A. P. Franken, Arlene L. Oei, Johannes Crezee, H. Petra Kok
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:http://dx.doi.org/10.1080/02656736.2020.1852324